Matinas Biopharma Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • MTNB
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.87
  • (As of Friday Closing)

Matinas Biopharma General Information

Description

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Stock Exchange
ASE
Primary Office
  • 1545 Route 206 South
  • Suite 302
  • Bedminster, NJ 07921
  • United States
+1 (908) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Matinas Biopharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.87 $0.86 $0.66 - $2.22 $179M 204M 1.3M -$0.12

Matinas Biopharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 163,359 216,578 345,124 72,445
Revenue 192 158 90 120
EBITDA (22,242) (21,672) (16,592) (14,372)
Net Income (22,357) (22,447) (17,373) (14,083)
Total Assets 72,351 70,967 40,240 19,943
Total Debt 3,626 3,750 4,228 391
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Matinas Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Matinas Biopharma‘s full profile, request access.

Request a free trial

Matinas Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of
Biotechnology
Bedminster, NJ
20 As of 2020
000.00
000000 - 000 000.00

00000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000 000000000
San Diego, CA
000 As of 0000
000.00
000000000 000.00

00000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
0000000000000
Alameda, CA
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Matinas Biopharma Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arcturus Therapeutics Formerly Accelerator/Incubator backed San Diego, CA 000 000.00 000000000 000.00
00000000 Corporation Alameda, CA 00 000000000 -
000000 00000000 00 Formerly PE-Backed Ann Arbor, MI 000 000000000000
0000000 Corporation Branford, CT
00000000 Formerly VC-backed London, United Kingdom 000 00000 000000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Matinas Biopharma Executive Team (8)

Name Title Board Seat Contact Info
Jerome Jabbour JD Chief Executive Officer & Board Member
Keith Kucinski Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Hui Liu Ph.D Chief Technology Officer, Technology
Raphael Mannino Ph.D Chief Scientific Officer
Theresa Matkovits Executive
You’re viewing 5 of 8 executive team members. Get the full list »

Matinas Biopharma Board Members (6)

Name Representing Role Since
Eric Ende Self Board Member 000 0000
Herbert Conrad Self Chairman & Board Member 000 0000
James Scibetta Self Board Member 000 0000
Jerome Jabbour JD Matinas Biopharma Chief Executive Officer & Board Member 000 0000
Natasha Giordano Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Matinas Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Matinas Biopharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 30-Jan-2015 000000000000000000 00.00 Other Healthcare Technology Systems 000000 000000
To view Matinas Biopharma’s complete acquisitions history, request access »

Matinas Biopharma Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Other Healthcare Technology Systems Chicago, IL 0000
To view Matinas Biopharma’s complete subsidiaries history, request access »